Poland· PL-100444604

Ornispar

A liver therapy product containing ornithini aspartas, registered in Poland by Solinea Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC A05BA

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOrnisparATCA05BAREGISTER NO.PL-100444604PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Ornithini aspartas is registered in 3 of 19 countries.

Countries holding a registration under ATC A05BA (liver therapy), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Ornithini aspartas · ATC A05BA

3 / 19 countries

  • Belgiumprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ornithini aspartas
Manufacturer
Solinea Sp. z o.o.
Country
Poland (PL)
ATC code
A05BA
ATC class
Liver therapy
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991487966
  • gtin
    05909991487980
  • gtin
    05909991488000
  • gtin
    05909991487997
  • gtin
    05909991487973

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ornithini aspartas in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ornithini aspartas products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea2faaf8-6d79-49ae-997d-cc711f21e049
GET /v1/drugs/ea2faaf8-6d79-49ae-997d-cc711f21e049?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulat do sporządzania roztworu doustnego, w saszetce",
  "source": "urpl",
  "strength": "3 g/5 g",
  "packaging": "05909991487973 ¦ Rp ¦ 143961\n30 sasz. 5 g\n05909991487966 ¦ Rp ¦ 143962\n20 sasz. 5 g\n05909991487980 ¦ Rp ¦ 143963\n10 sasz. 5 g\n05909991488000 ¦ Rp ¦ 143964\n100 sasz. 5 g\n05909991487997 ¦ Rp ¦ 143965\n50 sasz. 5 g",
  "substance": "Ornithini aspartas 3000 mg/5 g",
  "common_name": "Ornithini aspartas",
  "pl_product_id": "100444604",
  "pozwolenie_nr": "27171",
  "auth_procedure": "NAR",
  "authorisation_validity": "2027-07-11"
}

See everything about ornithini aspartas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.